Ivo Winiger - Free People Check with News, Pictures & Links

	Houston Reno

	Oncology Novartis Zytiga Winiger-Candolfi Africa Janssen Oncology Oncology Solid Tumor Solid Tumor Therapy

Images of Ivo Winiger

(0 from 0 )

News

(1 - 4 from 19

–show all

)

Hautkrebs: Warum neue Therapien so sensationell sind | kurier.at

kurier.at

... Kuhn spricht mit dem Spezialisten Univ.-Prof. Dr. Hubert Pehamberger (früher MedUni Wien, jetzt Rudolfinerhaus), Dr. Ivo Winiger (Novartis Oncology) ...

Apalutamide: efficacia confermatanella terapia del tumore prostatico...

www.liberoquotidiano.it

liberoquotidiano.it

Bild: Neue Hoffnung für Patienten mit Lungenkrebs durch...

www.ots.at

Neue Behandlungsmöglichkeit für Lungenkrebspatienten. Im Bild v.l.n.r.: Dr. IVO WINIGER, Medical Affairs Head von Novartis Oncology in Österreich; OA Dr....

News - Focus On, Ivo Winiger-Candolfi - The Pharma Letter

www.thepharmaletter.com

European Commission expands license for Janssen's Zytiga The European Commission has given its backing to broaden the existing marketing authorization for Zytiga… Filter. Current filters: Focus OnIvo Winiger-Candolfi. Popular Filters. AnalgesiaAnti-Arthritics/RheumaticsAnti-viralsAntibiotics and Infectious ...

Telephone & Addresses

Ivo J Winiger, Reno, Watercress Cir

View Ivo's social profiles and photos on Facebook, MySpace, and +40 Networks.

local.ch: Ivo winiger à Suisse dans l'annuaire téléphonique >> Trouvez...

Winiger-Candolfi Carole und Ivo. Zumhofrain 2, Kriens Téléphone * · Détails. Agrandir carte. ivo winiger - 2 Résultats sur local.ch. Service clientèle. Contacter · Questions fréquentes · Conditions Générales (CG) · Publicité.

Network Profiles

Facebook: Ivo Winiger | Facebook

LinkedIn: Ivo Winiger, MD | LinkedIn

Sehen Sie sich das berufliche Profil von Ivo Winiger, MD (Schweiz) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und

Interests

European Commission Extends License for Janssen’s ZYTIGA® Plus...

www.businesswire.com

We are encouraged by the data we have seen to date and remain committed to transforming outcomes for prostate cancer patients,” said Dr. Ivo Winiger-Candolfi, Oncology Solid Tumor Therapy Area Lead, Janssen Europe, Middle East and Africa. Abiraterone acetate plus prednisone / prednisolone has ...

Business Profiles

Xing: Ivo Winiger

Global Clinical Leader, Oncology Global Development / Bern, Schweiz

Publications

European Commission widens Janssen's existing marketing authorisation...

www.thefreelibrary.com

Free Online Library: European Commission widens Janssen's existing marketing authorisation for Zytiga. by

Reports & Statements

Erleada (apalutamide) gets positive opinion from the EMA | Approvals...

everyone.org

Dr Ivo Winiger-Candolfi M.D. of Janssen Oncology stated, "[T]oday's positive CHMP opinion brings us one step closer to offering patients an ...

La UE autoriza apalutamida de Janssen para cáncer de próstata ...

www.infectoforum.net

... una nueva opción de tratamiento”, afirma Ivo Winiger-Candolfi, director del Área de Tratamiento de Tumores Sólidos de Janssen Oncology, ...

Miscellaneous

(1 - 20 from 37

–show all

)

Ivo Winiger | LinkedIn

www.linkedin.com

View Ivo Winiger's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Ivo Winiger discover inside

Ivo Winiger-Candolfi, MD | LinkedIn

www.linkedin.com

View Ivo Winiger-Candolfi, MD’S professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Ivo Winiger-Candolfi ...

Janssen Submits Marketing Authorisation Application for Apalutamide ...

finance.yahoo.com

... and delaying the cancer from spreading we aim to improve outcomes for patients with this devastating disease,” said Dr Ivo Winiger-Candolfi, ...

Christian Köberl, Christine Fischer, Ivo Winiger-Candolfi, Christian...

photaq.com

Bild/Image zu Christian Köberl, Christine Fischer, Ivo Winiger-Candolfi, Christian Singer : Leben mit der Diagnose Brustkrebs: Neue Hoffnung für Patientinnen :...

Winiger Ivo „Bäri“, Landwirt in Sulz/LU – SEHTAL

sehtal.com

Sehtal-Flip 001: Ivo

Ivo Winiger-Candolfi highlights how we are working to transform...

eaucongress.uroweb.org

Ivo Winiger-Candolfi highlights how we are working to transform #prostatecancer patients' outcomes and ultimately improve their quality of life #EAU

Die rüstige Veteranin Rosa und der quirlige Walter im Dauereinsatz -...

www.studhalter.org

... in Sulz erntet mit seiner betagten Erntemaschine "Rosa" kurz vor Sonnenuntergang das steile Feld unser Nachbarn Ivo Winiger. Raffi Budliger begleitet ...

El acetato de abiraterona aumenta la supervivencia en cáncer de...

www.redaccionmedica.com

El acetato de abiraterona mejora la supervivencia libre de progresión radiológica en pacientes con cáncer de próstata metastásico

Abiraterone Acetate Plus Prednisone Provided Significant Clinical...

www.emjreviews.com

Beerse, Belgium, 3 June, – Janssen-Cilag International NV today announced data from the pivotal Phase 3 LATITUDE clinical trial, which showed Zytiga...

Apalutamida (Janssen) reduce significativamente riesgo de metástasis...

sinerfarma.com.mx

... enfermedad devastadora”, declara el Dr. Ivo Winiger-Candolfi, Director del Área Terapéutica de Tumores Sólidos en Oncología del Janssen ...

Apalutamida para el tratamiento de cáncer de próstata resistente a la...

elmedicointeractivo.com

Noticias e información sobre salud y medicina

CHMP erteilt positiven Bescheid für die Ausweitung von ZYTIGA® von...

www.pharma-zeitung.de

Janssen Oncology hat bislang eine entscheidende Rolle dabei gespielt, die Behandlungsmethode von Prostatakrebs zu verändern und möchte noch weitere Fortschritte bewirken“, sagte Dr. Ivo Winiger-Candolfi, Oncology Solid Tumor Therapy Area Lead, Janssen Europa, Nahost, Afrika. Abirateronacetat ...

EMA committee recommends approval of Janssen's apalutamide to treat...

www.pharmabiz.com

... apalutamide for the treatment of patients with high-risk non-metastatic castration-resistant prostate cancer,” said Dr Ivo Winiger-Candolfi, MD, ...

El CHMP emite una opinión positiva para Erleada de Janssen

www.pmfarma.es

... declaró el Dr. Ivo Winiger-Candolfi M.D., Director del Área de Tratamiento de Tumores Sólidos de Janssen Oncology, Europa, Oriente Medio ...

EU Approves Abiraterone for Newly Diagnosed Hormone-Sensitive...

www.onclive.com

“This EC approval is a major step forward for men living with prostate cancer across Europe and offers patients with newly diagnosed high-risk metastatic hormone-sensitive prostate cancer a new treatment option,” Ivo Winiger-Candolfi, MD, oncology solid tumor therapy area lead, Janssen Europe, Middle ...

Europa autoriza Erleada, de Janssen, para cáncer de próstata

www.redaccionmedica.com

Ivo Winiger-Candolfi, director del Área de Tratamiento de Tumores Sólidos de Janssen Oncology en Europa, Oriente Medio y África, asegura: ...

Janssen announces European Commission approval of ERLEADA®...

www.biospace.com

... castration-resistant prostate cancer a new treatment option,” said Dr Ivo Winiger-Candolfi M.D., Janssen Oncology Solid Tumor Therapy Area ...

Janssen presentará nuevos datos de Zytiga para cáncer de próstata -...

www.pacientesenbuenasmanos.com

... en ayudar a redefinir ese camino”, señala el Doctor Ivo Winiger-Candolfi, Oncology Solid Tumor Therapy Area Leader de Janssen.

Janssen presentará 14 trabajos en ASCO | Noticias del sector...

www.acobur.es

Entendemos que cada paciente con cáncer se enfrenta a un camino diferente y estamos comprometidos en ayudar a redefinir ese camino", señala el Doctor Ivo Winiger-Candolfi, Oncology Solid Tumor Therapy Area Leader de Janssen. "Particularmente, estamos deseando presentar los resultados del ...